Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer

Leonie Hartl1,2, Marieke S Ten Brink3, Hella L Aberson1,2

  • 1Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Insights

Hypoxia counteracts the tumor-suppressive effects of C/EBPδ in pancreatic cancer. This study reveals a feedback loop with HIF-1α, highlighting the importance of oxygen levels in preclinical models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of 13%.
  • The role of key molecules in PDAC development is context-dependent, complicating research.
  • Transcription factor C/EBPδ exhibits tumor-suppressive effects in vitro in PDAC cells.

Purpose of the Study:

  • To investigate the role of C/EBPδ in a mouse model of PDAC.
  • To understand how physiological conditions, specifically hypoxia, affect C/EBPδ function in PDAC.
  • To elucidate the interaction between C/EBPδ and hypoxia-inducible factor 1-alpha (HIF-1α).

Main Methods:

  • In vivo assessment of C/EBPδ in a mouse PDAC model.
  • RNA sequencing of C/EBPδ-induced cells under hypoxic conditions.
  • In vitro proliferation assays to evaluate C/EBPδ activity under varying oxygen tensions.

Main Results:

  • Hypoxia in vivo counteracts the tumor-suppressive effects of C/EBPδ.
  • A reciprocal feedback loop between C/EBPδ and HIF-1α was identified.
  • The growth-limiting effects of C/EBPδ diminish with decreasing oxygen levels, abrogating its tumor-suppressive activity in vitro.

Conclusions:

  • Physiological parameters like hypoxia significantly influence the function of tumor-associated molecules in PDAC.
  • Preclinical models must account for in vivo conditions, such as oxygen tension, for accurate results.
  • Understanding context-dependent molecular roles is crucial for developing effective PDAC therapies.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K